BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8451409)

  • 1. Enhancement of joint fluid with intravenously administered gadopentetate dimeglumine: technique, rationale, and implications.
    Winalski CS; Aliabadi P; Wright RJ; Shortkroff S; Sledge CB; Weissman BN
    Radiology; 1993 Apr; 187(1):179-85. PubMed ID: 8451409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR diagnosis of recurrent tears in the knee: value of intraarticular contrast material.
    Applegate GR; Flannigan BD; Tolin BS; Fox JM; Del Pizzo W
    AJR Am J Roentgenol; 1993 Oct; 161(4):821-5. PubMed ID: 8372768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect MR arthrography: optimization and clinical applications.
    Vahlensieck M; Peterfy CG; Wischer T; Sommer T; Lang P; Schlippert U; Genant HK; Schild HH
    Radiology; 1996 Jul; 200(1):249-54. PubMed ID: 8657921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of intravenous gadopentetate dimeglumine in magnetic resonance imaging of synovial lesions.
    Whitten CG; Moore TE; Yuh WT; Kathol MH; Renfrew DL; Walker CW
    Skeletal Radiol; 1992; 21(4):215-8. PubMed ID: 1626287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
    Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
    AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lumbosacral spine: early and delayed MR imaging after administration of an expanded dose of gadopentetate dimeglumine in healthy, asymptomatic subjects.
    Jinkins JR; Rauch RA; Gee GT; Bazan C; Xiong L; Kashanian FK; Hanna EP
    Radiology; 1995 Oct; 197(1):247-51. PubMed ID: 7568831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
    Strouse PJ; Prince MR; Chenevert TL
    Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of normal and abnormal fluid collections in the glenohumeral joint: implications for MR arthrography.
    Recht MP; Kramer J; Petersilge CA; Yu J; Pathria M; Trudell D; Sartoris DJ; Resnick D
    J Magn Reson Imaging; 1994; 4(2):173-7. PubMed ID: 8180457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Low-Dose Higher-Relaxivity and Standard-Dose Lower-Relaxivity Contrast Media for Delayed-Enhancement MRI: A Blinded Randomized Crossover Study.
    Cheong BY; Duran C; Preventza OA; Muthupillai R
    AJR Am J Roentgenol; 2015 Sep; 205(3):533-9. PubMed ID: 26295638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 11. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
    Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
    AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravenous MR arthrography of the knee].
    Yamato M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Jun; 55(7):466-9. PubMed ID: 7644336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
    Jensen MC; Brant-Zawadzki M
    AJR Am J Roentgenol; 1993 Jan; 160(1):153-7. PubMed ID: 8416615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
    Tishler S; Hoffman JC
    AJNR Am J Neuroradiol; 1990; 11(6):1167; discussion 1168-9. PubMed ID: 2124049
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical shift misregistration artifact: increased conspicuity following intravenous administration of gadopentetate dimeglumine.
    Apicella PL; Mirowitz SA; Borrello JA
    Magn Reson Imaging; 1994; 12(4):675-8. PubMed ID: 8057773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of gadodiamide injection and gadopentetate dimeglumine in anesthetized dogs.
    Peters JL; Shaw DD
    Acta Radiol; 1993 Sep; 34(5):510-6. PubMed ID: 8369191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical safety of gadopentetate dimeglumine.
    Nelson KL; Gifford LM; Lauber-Huber C; Gross CA; Lasser TA
    Radiology; 1995 Aug; 196(2):439-43. PubMed ID: 7617858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast enhancement of the gastrointestinal tract on MR images using intravenous gadolinium-DTPA.
    Mirowitz SA
    Abdom Imaging; 1993; 18(3):215-9. PubMed ID: 8508075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation.
    Drapé JL; Thelen P; Gay-Depassier P; Silbermann O; Benacerraf R
    Radiology; 1993 Jul; 188(1):227-34. PubMed ID: 8511303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cardiovascular changes after administration of gadodiamide injection and gadopentetate dimeglumine in dogs.
    Bøkenes J; Hustvedt SO; Refsum H
    Acad Radiol; 1997 Mar; 4(3):204-9. PubMed ID: 9084778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.